Meta-Analysis of population studies on the prevalence of chronic pain in UK – Pubrica

A Meta-Analysis of Population Studies on the Prevalence of Chronic Pain in UKA Meta-Analysis of Population Studies on the Prevalence of Chronic Pain in UK
An Academic presentation by
Conclusions
Outline
TODAY'S DISCUSSION
Chronic pain, which includes illnesses like low back pain and osteoarthritis, was recently highlighted as one of the most common causes of disability worldwide by the Global Burden of Disease studies in a meta-anal y sis study .
National governments have begun to acknowledge chronic pain as a key concern and challenge for their public health and healthcare systems, resulting in national plans and the convening of Pain Summits in countries such as the UK, US and Europe.
Contd...
As with other long-term conditions like cancer and cardiovascular disease, such initiatives emphasize the importance of accurate population-based estimates of chronic pain in helping to drive and inform policies of prevention and care, needs assessments, and surveillance of the impact of interventions.
Despite multiple high-profile national publications emphasizing the importance of chronic pain in the UK, there is little agreement on the country's pain burden.
According to one estimate, up to 8 million people in the UK suffer from chronic pain, which corresponds to a telephone poll of European citizens in which 13% of the UK population reported pain of moderate-to-severe intensity that lasted for more than 6 months.
Estimates based on definitions more closely aligned with those of the International Association for the Study of Pain: "pain that persists beyond normal tissue healing time, which is believed to be 3 months" was significantly higher than those cited in the European telephone survey.
The goal of this clinical meta-anal ysis study was to compile available data on the prevalence of various chronic pain classifications in the general population to generate much- needed, reliable, and current national estimates.
Numerous physical, psychological, and social variables contribute to chronic pain.
Risk factors have traditionally been categorized as "modifiable" or "non-modifiable," however, this bio- medico-centric approach to epidemiology does not always account for the intricate interplay between modifiable and non-modifiable parts of each risk factor.
The individual's explanation of these events and their impact on their life and health, on the other hand, is constantly changing, and this will affect their future health and life.
FACTORS ASSOCIATED WITH CHRONIC PAIN
In addition, interventions that strengthen the biopsychosocial determinants of health can help to prevent or reduce future
population exposure to risk factors linked to chronic pain.
Age, gender, ethnicity and cultural background, socioeconomic status, and lifestyle and behaviour are all considered factors.
Identifying and managing modifiable risk factors and elements of risk factors may help avoid chronic pain or reduce its duration and severity.
Meta anal ysis research factors that cannot be treated with medicine are relevant to discuss in a clinical setting.
Contd...
Many of these are pertinent to chronic pain predictions, evaluations, treatment, and prognoses, while others will be crucial in searching for new therapeutic targets.
Chronic pain
patient-centered approach.
The prevalence of chronic pain in the UK is estimated to be 43% based on the highest quality research of general population samples.
Meta-anal ysis in research of chronic pain prevalence increases steadily with age, affecting up to 62% of the population over the age of 75, implying that the burden of chronic pain may rise even more as the population ages if the incidence remains unchanged.
According to weighted averages, widespread chronic pain affects 14.2% of the population.
Between 10.4% and 14.3% of the population suffers from either moderately or severely restricting chronic pain, resulting in an estimated 7.9 million persons in the UK with this condition.
Given the meta-analysis heterogeneity in this field, which stems from differences in how chronic pain is characterized in each study and the populations analyzed, chronic pain epidemiology was chosen.
The latter may impact the study's generalizability to other people, regions, or countries.
Differences in study design also limit individual research findings.
LIMITATIONS
Pubrica offers the best Clinical Meta-anal y sis services for clinical industries for younger researchers.
We examine the best available statistics to show that chronic pain affects one-third to half of the population in the UK.
Contd...